Hypothalamic arousal regions are activated during modafinil-induced wakefulness

Journal of Neuroscience

Volumn 20, Issue 22, 2000, Pages 8620-8628

  Scammell, T E ^a   Estabrooke, I V ^a   McCarthy, M T ^a   Chemelli, R M ^a   Yanagisawa, M ^a   Miller, M S ^a   Saper, C B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Amygdala; Anterior hypothalamic area; Dopamine; Fos; Hypocretin; Lateral hypothalamic area; Modafinil; Narcolepsy; Orexin; Perifornical area; Stimulant; Striatum; Suprachiasmatic nucleus; Tuberomammillary nucleus

Indexed keywords

MODAFINIL; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; AROUSAL; ARTICLE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; DOPAMINE METABOLISM; DRUG EFFECT; HYPOTHALAMUS; HYPOTHALAMUS NUCLEUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NARCOLEPSY; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SLEEP WAKING CYCLE; SUPRACHIASMATIC NUCLEUS; WAKEFULNESS;

EID: 0034668848     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-22-08620.2000     Document Type: Article

References (43)

1. Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity
2. Amygdala and extended amygdala
3. Rat strain differences in response to dark pulse triggering of paradoxical sleep
4. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy
5. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation
6. D1 dopamine receptor activation of multiple transcription factor genes in rat striatum
7. A comparison of the preclinical pharmacology of modafinil and amphetamine-like drugs
8. Dopamine receptor-mediated regulation of corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus
9. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat
10. Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration
11. Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil
12. Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: Comparison with amphetamine
13. The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: Possible involvement of the serotonergic 5-HT3 receptor
14. The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: Evidence for a preferential inhibition of striato-pallidal GABA transmission
15. Quantification without pontification: Choosing a method for counting objects in sectioned tissues
16. Orexin A activates locus coeruleus cell firing and increases arousal in the rat
17. Organization of histaminergic fibers in the rat brain
18. Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat
19. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity
20. Evidence for histaminergic arousal mechanisms in the hypothalamus of cat
21. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats
22. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat
23. Hypothalamo-preoptic histaminergic projections in sleep-wake control in the cat
24. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat
25. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene
26. Induction of paradoxical sleep by lights-off stimulation
27. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep
28. Modafinil binds to the dopamine uptake carrier site with low affinity
29. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
30. Bed nucleus of the stria terminalis: Cytoarchitecture, immunohistochemistry, and projection to the parabrachial nucleus in the rat
31. Pharmacological aspects of human and canine narcolepsy
32. Neurons containing hypocretin (orexin) project to multiple neuronal systems
33. Expression of c-fos protein in brain: Metabolic mapping at the cellular level
34. Activation of ventrolateral preoptic neurons by the somnogen prostaglandin D2
35. Activation of ventrolateral preoptic neurons during sleep
36. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat
37. The central nucleus of the amygdala (ACE) does not mediate the effects of modafinil
38. State-dependent discharge of neurons in the rat posterior hypothalamus
39. Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats
40. Modafinil and cortical gamma-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins
41. Specific neurons for wakefulness in the posterior hypothalamus in the cat
42. D1 dopamine receptors mediate neuroleptic-induced Fos expression in the islands of Calleja
43. Electrophysiology of excitatory and inhibitory afferents to rat histaminergic tuberomammillary nucleus neurons from hypothalamic and forebrain sites